Scientist

A University of Alabama at Birmingham study has identified a gene deletion in nearly 25 percent of all glioblastoma cases that is believed to be responsible for poor patient outcomes. The discovery could lead to better diagnosis and targeted treatments with drugs that are currently available.

Main Image: 

2010 Annual Scientific Retreat

Thursday, September 30, 2021 to Friday, October 1, 2021

Thursday, September 308:30 – 9:00 – Welcome, Chairman’s Remarks, and Introductions

Karen Avery
Director of Foundation Relations, Smithsonian Institution

Steve Case
Chairman, Accelerate Brain Cancer Cure

Max Wallace
CEO, Accelerate Brain Cancer Cure

9:00 – 9:30 – Clinical Treatment of GBM – Where Are We and Where Do We Need to Go?

Mike Prados
Director of Translational Research in Neuro-Oncology, UCSF

9:45 – 12:00 – Molecular Elucidation of Brain Cancer

Lynda Chin
Professor of Dermatology, Harvard Medical School

Stephen Friend
President, Co-Founder and Director, Sage BioNetworks

Markus Bredel
Director, Radiation Oncology Brain Tumor Laboratory, UAB

1:00– 2:45 – New Strategies and Opportunities in Targeting GBM

Paul Mischel
Professor of Pathology, UCLA

Heidi Phillips
Senior Scientist, Genentech

David Schenkein
CEO, Agios Pharmaceuticals

3:00 – 4:15    

Martin Brown
Director, Division of Radiation and Cancer Biology, Stanford

Graeme Bilbe
Global Head of Neuroscience Research, Novartis

Friday, October 18:30 – 9:00 – Integration of Clinical Genomics into the Discovery and Development of Novel Cancer Therapies

Neil Gibson
Vice President and Chief Scientific Officer, Pfizer Oncology

9:00 – 11:00 – New Initiatives in Preclinical Animal Models for GBM

Terry Van Dyke
Chief, Mouse Cancer Genetics Program, NCI

David James
Professor of Neurological Surgery, UCSF

Neal Goodwin
The Jackson Laboratories

11:00 – 11:30 – New Clinical Trials in Brain Cancer

Karen Aboody
Associate Professor, Neurosciences, City of Hope

11:30 – 11:45 – Closing Remarks

Max Wallace
CEO, Accelerate Brain Cancer Cure

Share |

Join us in our fight for a cure!

Twitter